From $6,380 to $700,508: Adia pushes deeper into stem cell treatment
Adia Nutrition (OTCQB: ADIA) reporting fiscal 2025 results and strategic shift to regenerative medicine. Income rose to $700,508 from $6,380 in 2024, with a gross profit of $191,670. The company recorded an operating loss of $366,492 and a net loss of $395,464 and expressed doubts about the concern. Adia achieved … Read more